VioQuest Pharmaceuticals, Inc.
VOQP · OTC
6/30/2008 | 3/31/2008 | 12/31/2007 | 9/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $473 | $979 | $1,195 | $1,474 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $555 | $690 | $486 | $1,199 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,028 | $1,669 | $1,680 | $2,673 |
| Operating Income | $1,028 | $1,669 | $2,644 | $2,673 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,028 | -$1,669 | -$2,644 | -$2,673 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $103 | $1,412 | $1,339 | $209 |
| Net Income | -$1,131 | -$3,081 | -$3,019 | -$2,882 |
| % Margin | – | – | – | – |
| EPS | -0.23 | -0.63 | -0.631 | -0.63 |
| % Growth | 63.5% | 0.1% | -0.1% | – |
| EPS Diluted | -0.23 | -0.63 | -0.631 | -0.63 |
| Weighted Avg Shares Out | 4,905 | 4,905 | 4,789 | 4,606 |
| Weighted Avg Shares Out Dil | 4,905 | 4,905 | 4,789 | 4,606 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $103 | $1,412 | $616 | $542 |
| Depreciation & Amortization | $2 | $2 | $635 | $565 |
| EBITDA | -$1,025 | -$1,667 | -$1,045 | -$2,108 |
| % Margin | – | – | – | – |